                         SEQUENCE LISTING

<110>  Immunity Pharma Ltd.
       OVADIA, Eran
       BEN-SHIMON, Avi
       COHEN, Ilana
 
<120>  PEPTIDE COMPOUNDS AND METHODS OF TREATING DISEASES USING SAME

<130>  84727

<150>  IL 272074
<151>  2020-01-15

<160>  45    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  1

Leu Pro Pro Leu Xaa Tyr Pro 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  2

Leu Pro Pro Leu Pro Tyr Xaa 
1               5           


<210>  3
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is 2-Aminoisobutyric acid (Aib)

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is 2-Aminoisobutyric acid (Aib)

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  C terminal amidated

<400>  3

Xaa Pro Pro Leu Xaa Tyr Xaa 
1               5           


<210>  4
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-proline

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is 2-Aminoisobutyric acid (Aib)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  C terminal amidated

<400>  4

Xaa Pro Leu Xaa Tyr 
1               5   


<210>  5
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is 2-Aminoisobutyric acid (Aib)

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  C terminal amidated

<400>  5

Xaa Pro Pro His Xaa Tyr 
1               5       


<210>  6
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is D-leucine

<400>  6

Leu Pro Pro Xaa Pro Tyr Pro 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  dimethylproline

<400>  7

Leu Pro Pro Leu Pro Tyr Pro 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  8

Leu Pro Pro Val Pro Tyr Pro 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  9

Leu Pro Pro Ser Pro Tyr Pro 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  10

Leu Pro Pro His Pro Tyr Pro 
1               5           


<210>  11
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<400>  11

Xaa Pro Pro His Pro Tyr Pro 
1               5           


<210>  12
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  12

Xaa Pro Xaa Leu Ala Tyr Pro 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  dimethylproline

<400>  13

Leu Pro Pro Leu Pro Tyr Pro 
1               5           


<210>  14
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  14

Leu Pro Xaa Leu Pro Tyr Pro 
1               5           


<210>  15
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  15

Leu Xaa Pro Leu Pro Tyr Pro 
1               5           


<210>  16
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  16

Leu Pro Pro Ala Pro Tyr Pro 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is D-proline

<400>  17

Leu Pro Pro Leu Pro Tyr Xaa 
1               5           


<210>  18
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Acetylated

<400>  18

Leu Pro Pro Leu Pro Tyr Pro 
1               5           


<210>  19
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  19

Leu Pro Pro Asn Pro Tyr Pro 
1               5           


<210>  20
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  20

Pro Pro Leu Ala Tyr 
1               5   


<210>  21
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  21

Leu Pro Pro Leu Tyr Tyr Pro 
1               5           


<210>  22
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  22

Leu Pro Pro Leu His Tyr Pro 
1               5           


<210>  23
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  23

Leu Pro Pro Leu Leu Tyr Pro 
1               5           


<210>  24
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  24

Leu Pro Pro Leu Pro Phe Pro 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-arginine

<400>  25

Xaa Pro Pro Leu Pro Tyr Pro 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  26

Leu Pro Pro Thr Pro Tyr Pro 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  27

Leu Pro Pro Leu Pro Trp Pro 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is D-valine

<400>  28

Leu Pro Pro Leu Pro Xaa Pro 
1               5           


<210>  29
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is D-aspartic acid

<400>  29

Leu Pro Pro Leu Pro Xaa Pro 
1               5           


<210>  30
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  30

Pro Pro His Pro Tyr 
1               5   


<210>  31
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  31

Leu Pro Pro His Pro Tyr Pro 
1               5           


<210>  32
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<400>  32

Xaa Pro Pro His Ala Tyr Pro 
1               5           


<210>  33
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  33

Xaa Xaa Pro Leu Ala Tyr Pro 
1               5           


<210>  34
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is D-proline

<400>  34

Leu Pro Xaa Leu Pro Tyr Pro 
1               5           


<210>  35
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  35

Leu Pro Pro His Xaa Tyr Pro 
1               5           


<210>  36
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  36

Xaa Pro Pro His Xaa Tyr Pro 
1               5           


<210>  37
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Acetylated

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is 2-Aminoisobutyric acid (Aib)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  C terminal amidated

<400>  37

Pro Pro Leu Xaa Tyr 
1               5   


<210>  38
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  38

Xaa Pro Pro Leu Xaa Tyr Pro 
1               5           


<210>  39
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  39

Xaa Pro Pro Leu Xaa Tyr 
1               5       


<210>  40
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<400>  40

Xaa Pro Pro Leu Ala Tyr 
1               5       


<210>  41
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is D-leucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is 2-Aminoisobutyric acid (Aib)

<400>  41

Xaa Pro Pro Leu Ala Tyr Xaa 
1               5           


<210>  42
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  42

Leu Pro Pro Leu Pro Tyr Pro 
1               5           


<210>  43
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  43

Pro Pro Leu Pro Tyr 
1               5   


<210>  44
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  44

Leu Pro Pro Leu Ala Tyr Pro 
1               5           


<210>  45
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is either  leucine, d-leucine, d-valine, d-arginine or absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is either dimethylproline (dMP), proline, a-aminoisobutyric 
       acid (Aib) or d-proline;

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is either dimethylproline (dMP),  proline,  Aib or d-proline

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is either histidine, serine, valine, leucine, d-leucine or 
       threonine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is either proline or alanine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is either tyrosine, d-valine, d-aspartic acid, tryptophan or 
       phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is either proline, dMP, d-proline or absent

<400>  45

Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5           


